These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38100464)

  • 21. Significance of Statin-Associated Muscle Symptoms and Its Impact on Patients Adherence and Outcomes.
    Al-Makhamreh HK; Toubasi AA; Obaid YY; Albustanji FH
    J Cardiovasc Pharmacol; 2023 Mar; 81(3):185-191. PubMed ID: 36459061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin-associated muscle symptoms in coronary patients: design of a randomized study.
    Munkhaugen J; Vethe NT; Fagerland MW; Dammen T; Perk J; Gjertsen E; Otterstad JE; Gullestad L; Bergan S; Husebye E
    Scand Cardiovasc J; 2019 Jun; 53(3):162-168. PubMed ID: 31030568
    [No Abstract]   [Full Text] [Related]  

  • 23. Practical aspects in the management of statin-associated muscle symptoms (SAMS).
    Laufs U; Filipiak KJ; Gouni-Berthold I; Catapano AL;
    Atheroscler Suppl; 2017 Apr; 26():45-55. PubMed ID: 28434484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coenzyme Q10 supplementation for the treatment of statin-associated muscle symptoms.
    Chen W; Ochs-Balcom HM; Ma C; Isackson PJ; Vladutiu GD; Luzum JA
    Future Cardiol; 2022 Jun; 18(6):461-470. PubMed ID: 35297269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolomics of dietary fatty acid restriction in patients with phenylketonuria.
    Mütze U; Beblo S; Kortz L; Matthies C; Koletzko B; Bruegel M; Rohde C; Thiery J; Kiess W; Ceglarek U
    PLoS One; 2012; 7(8):e43021. PubMed ID: 22912778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment Options for Statin-Associated Muscle Symptoms.
    Laufs U; Scharnagl H; Halle M; Windler E; Endres M; März W
    Dtsch Arztebl Int; 2015 Oct; 112(44):748-55. PubMed ID: 26575138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial.
    Kristiansen O; Vethe NT; Peersen K; Wang Fagerland M; Sverre E; Prunés Jensen E; Lindberg M; Gjertsen E; Gullestad L; Perk J; Dammen T; Bergan S; Husebye E; Otterstad JE; Munkhaugen J
    Eur Heart J Cardiovasc Pharmacother; 2021 Nov; 7(6):507-516. PubMed ID: 32609361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curcumin: An effective adjunct in patients with statin-associated muscle symptoms?
    Sahebkar A; Saboni N; Pirro M; Banach M
    J Cachexia Sarcopenia Muscle; 2017 Feb; 8(1):19-24. PubMed ID: 27897416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolomic analyses reveal lipid abnormalities and hepatic dysfunction in non-human primate model for Yersinia pestis.
    Gautam A; Muhie S; Chakraborty N; Hoke A; Donohue D; Miller SA; Hammamieh R; Jett M
    Metabolomics; 2018 Dec; 15(1):2. PubMed ID: 30830480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).
    Penson PE; Bruckert E; Marais D; Reiner Ž; Pirro M; Sahebkar A; Bajraktari G; Mirrakhimov E; Rizzo M; Mikhailidis DP; Sachinidis A; Gaita D; Latkovskis G; Mazidi M; Toth PP; Pella D; Alnouri F; Postadzhiyan A; Yeh HI; Mancini GBJ; von Haehling S; Banach M;
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1596-1622. PubMed ID: 35969116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skeletal muscle mitochondrial capacity in patients with statin-associated muscle symptoms (SAMS).
    Mangone LA; Taylor BA; Schmelzer R; Noh SG; White MC; Kwon OS; Thompson PD
    Open Heart; 2024 Feb; 11(1):. PubMed ID: 38388189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis.
    Chen C; Hou G; Zeng C; Ren Y; Chen X; Peng C
    Theranostics; 2021; 11(2):754-767. PubMed ID: 33391503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study.
    Cala MP; Agulló-Ortuño MT; Prieto-García E; González-Riano C; Parrilla-Rubio L; Barbas C; Díaz-García CV; García A; Pernaut C; Adeva J; Riesco MC; Rupérez FJ; Lopez-Martin JA
    J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):348-357. PubMed ID: 29464940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of statin-associated skeletal muscle-associated symptoms.
    Bouitbir J; Sanvee GM; Panajatovic MV; Singh F; Krähenbühl S
    Pharmacol Res; 2020 Apr; 154():104201. PubMed ID: 30877064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase.
    Würtz P; Wang Q; Soininen P; Kangas AJ; Fatemifar G; Tynkkynen T; Tiainen M; Perola M; Tillin T; Hughes AD; Mäntyselkä P; Kähönen M; Lehtimäki T; Sattar N; Hingorani AD; Casas JP; Salomaa V; Kivimäki M; Järvelin MR; Davey Smith G; Vanhala M; Lawlor DA; Raitakari OT; Chaturvedi N; Kettunen J; Ala-Korpela M
    J Am Coll Cardiol; 2016 Mar; 67(10):1200-1210. PubMed ID: 26965542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COQ2 polymorphisms are not associated with increased risk of statin-induced myalgia/myopathy in the Czech population.
    Hubacek JA; Adamkova V; Zlatohlavek L; Steiner-Mrazova L; Vrablik M
    Drug Metab Pers Ther; 2017 Dec; 32(4):177-182. PubMed ID: 29257754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statin intolerance.
    Laufs U; Scharnagl H; März W
    Curr Opin Lipidol; 2015 Dec; 26(6):492-501. PubMed ID: 26780003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation.
    Sampey BP; Freemerman AJ; Zhang J; Kuan PF; Galanko JA; O'Connell TM; Ilkayeva OR; Muehlbauer MJ; Stevens RD; Newgard CB; Brauer HA; Troester MA; Makowski L
    PLoS One; 2012; 7(6):e38812. PubMed ID: 22701716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy.
    Vinci P; Panizon E; Tosoni LM; Cerrato C; Pellicori F; Mearelli F; Biasinutto C; Fiotti N; Di Girolamo FG; Biolo G
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians.
    Wang Z; Tang J; Jin E; Zhong Y; Zhang L; Han X; Liu J; Cheng Y; Hou J; Shi X; Qi H; Qian T; Yuan L; Hou X; Yin H; Liang J; Zhao M; Huang L; Qu J
    Front Mol Biosci; 2022; 9():871291. PubMed ID: 35755823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.